Application 020941
- Type
- NDA
- Sponsor
- GLAXOSMITHKLINE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ABREVA | DOCOSANOL | CREAM;TOPICAL | 10% | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020941-001 | ABREVA | DOCOSANOL | 10% | CREAM / TOPICAL | RLD, RS | 2000-07-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N020941-001 | ABREVA | 10% | CREAM / TOPICAL | RLD, RS | 2000-07-25 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N020941-001 | ABREVA | 10% | CREAM / TOPICAL | RLD, RS | 2000-07-25 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N020941-001 | ABREVA | 10% | CREAM / TOPICAL | RLD, RS | 2000-07-25 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N020941-001 | ABREVA | 10% | CREAM / TOPICAL | RLD, RS | 2000-07-25 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ABREVA | DOCOSANOL | Haleon US Holdings LLC | c39b38a7-dcdd-4c32-8f35-b565c4d3cec6 | 2024-06-20 | Warnings | 020941 NDA020941 0135-0200 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0135-0200 | ABREVA | docosanol | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0135-0200 | ABREVA | docosanol | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 50090-3476 | ABREVA | docosanol | A-S Medication Solutions | NDA | Current |
| 50090-3476 | ABREVA | docosanol | A-S Medication Solutions | NDA | Current |
| 50090-3476 | ABREVA | docosanol | A-S Medication Solutions | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85769 | SUPPL | 2026-04-27 |
| 85692 | SUPPL | 2026-04-20 |
| 46952 | SUPPL | 2017-01-24 |
| 46874 | SUPPL | 2017-01-18 |
| 13789 | SUPPL | 2015-02-17 |
| 26258 | SUPPL | 2015-02-02 |
| 3814 | SUPPL | 2008-02-14 |
| 35686 | SUPPL | 2007-05-29 |
| 3813 | SUPPL | 2007-05-29 |
| 21293 | ORIG | 2001-08-21 |
| 26257 | ORIG | 2000-07-25 |
| 13788 | ORIG | 2000-07-25 |